文献速递心境障碍精神分裂症与精神病性障碍

情感-精神病谱系中小胶质细胞与犬尿氨酸通路的多模态改变

Multimodal microglial and kynurenine pathway alterations across the affective-psychosis spectrum: a systematic review of patterns, heterogeneity, and dimensional implications.
PubMed 文献 · Mol Psychiatry · 2026-04-21

该系统综述整合TSPO-PET、脑脊液犬尿氨酸代谢物及死后小胶质细胞研究,比较重性抑郁障碍(MDD)、双相障碍(BD)和精神分裂症(SCZ)。MDD的TSPO结合增高最可重复且异质性低于SCZ;SCZ以KYNA分支偏移为主;小胶质细胞改变更宜由生物亚组和症状维度解释。

要点

  • MDD在额边缘区TSPO结合增高,异质性低于SCZ。
  • SCZ最一致的生化信号是转向KYNA分支。
  • 小胶质细胞改变更宜由生物亚组和症状维度解释。

核心结论

  • 小胶质细胞相关改变更适合由生物亚组和症状维度而非分类诊断解释。

研究设计与样本

  • 系统综述整合人TSPO-PET、脑脊液犬尿氨酸代谢物及死后小胶质细胞与犬尿氨酸通路研究。
  • 定量合成聚焦MDD与SCZ比较,BD因数据有限仅作描述性整合。

主要发现

  • MDD显示最可重复的体内信号,扣带回、海马和前额叶皮层TSPO结合增高,异质性低于SCZ且精度更高。
  • MDD死后研究在诊断层面小胶质细胞密度或经典激活标志物多无显著增高,但提示细微稳态偏移。
  • BD的TSPO-PET仅单研究报告海马增高,死后小胶质细胞标志物诊断层面多无改变,自杀或精神病性分层显示亚组效应。
  • SCZ的TSPO-PET异质性大,呈小幅降低或无变化,死后研究显示激活标志物增高或稳态小胶质细胞特征丢失。
  • SCZ最一致的生化信号是转向KYNA分支,脑脊液和皮层KYNA增高,符合犬尿氨酸通路相关谷氨酸能失调。

关键数值与推荐

  • MDD额边缘区TSPO结合增高且异质性低于SCZ;SCZ脑脊液和皮层KYNA增高。
  • BD单研究TSPO-PET报告海马增高,亚组显示前扣带上游激活伴前额叶KMO降低。

临床怎么用

  • 临床解读小胶质细胞和犬尿氨酸通路标志物时应考虑症状维度与生物亚组而非仅凭诊断分类。
  • 未来研究需采用跨诊断维度表型、亚组分层、纵向设计和微胶质细胞特异性生物标志物。

局限性

  • TSPO-PET细胞特异性有限。
  • 样本量小。
  • 死后研究仅聚焦少数皮层/边缘区而非全脑覆盖。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immune dysregulation is implicated in patient subgroups in major depressive disorder (MDD), bipolar disorder (BD) and schizophrenia (SCZ), but the role of microglia across affective and psychotic illnesses remains unclear. We propose an integrative framework linking systemic immune drivers to microglia-related circuit engagement, cellular phenotype, and kynurenine pathway (KP) branch balance. We systematically reviewed human TSPO-PET, cerebrospinal fluid (CSF) KP metabolite, and postmortem microglial and KP studies. Quantitative synthesis focused on MDD versus SCZ. BD was integrated descriptively due to limited data. MDD showed the most reproducible in vivo signal, with increased TSPO binding in frontolimbic regions (cingulate cortex, hippocampus, prefrontal cortex), and had lower heterogeneity and higher precision than SCZ. Postmortem MDD findings were largely null for diagnosis-level increases in microglial density or classical activation markers, but suggested subtle homeostatic shifts. KP findings were localized and regionally dissociated, including cingulate QUIN-related microglial signals and reduced hippocampal QUIN immunoreactivity in single cohorts. BD evidence was sparse as TSPO-PET comprised a single study reporting hippocampal increases, and postmortem microglial markers were mostly unchanged at the diagnosis level, with suicide or psychosis stratification revealing subgroup effects. Also, BD KP data suggested anterior cingulate upstream activation with a psychosis-linked downstream signal (reduced prefrontal KMO) in a subgroup. In SCZ, TSPO-PET findings were heterogeneous with small decreases or no change, and postmortem studies indicated either activation-marker increases or loss of homeostatic microglial signatures. In addition, the most consistent biochemical signal in SCZ was a shift toward the KYNA branch (increased CSF KYNA and cortical KYNA), consistent with KP-linked glutamatergic dysregulation. Overall, microglia-related alterations appear better explained by biological subgroups and symptom dimensions than by categorical diagnoses, motivating future transdiagnostic studies with dimensional phenotyping, subgroup stratification, longitudinal designs, and microglia-specific biomarkers. Limitations include the limited cellular specificity of TSPO-PET, small sample sizes, and postmortem studies focusing on few cortical/limbic regions rather than whole-brain coverage.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Nussbaumer M, Guest PC, Schiltz K, et al. Multimodal microglial and kynurenine pathway alterations across the affective-psychosis spectrum: a systematic review of patterns, heterogeneity, and dimensional implications. Mol Psychiatry. 2026. PMID: 42014469. doi:10.1038/s41380-026-03614-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。